Transaction #11954 · Form 4 · 0001193125-25-293655
TEVA PHARMACEUTICAL INDUSTRIES LTD · Exercise / conversion · Ordinary Shares
TEVA PHARMACEUTICAL INDUSTRIES LTD · Transacted November 20, 2025 · Filed November 24, 2025
What does this filing report?
An SEC Form 4 filing for TEVA PHARMACEUTICAL INDUSTRIES LTD records an exercise / conversion involving Ordinary Shares on November 20, 2025. The reported quantity was 63,492. The filing date is November 24, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company CIK
- 0000818686
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 63,492
- Reported price
- Not reported · See footnotes
- Reference value
- Not reported
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 91,876
- Ownership description
- Not reported
- SEC acceptance time
- Nov 24, 2025, 4:03 PM EST
- 10b5-1 indication
- Indicated in filing
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Fox Christine ↗
EVP, Head of U.S. Commercial
CIK 0001998173
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- F2
- Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- F3
- The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2025.
- F4
- Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II.
- F5
- Restricted share units were granted on November 20, 2023, with 63,492 vested on each of November 20, 2024 and November 20, 2025, and 63,492 vesting on each of November 20, 2026 and November 20, 2027.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.